Harper Sean E 4
4 · AMGEN INC · Filed Jan 17, 2018
Insider Transaction Report
Form 4
AMGEN INCAMGN
Harper Sean E
EVP, Research & Development
Transactions
- Sale
Common Stock
2018-01-16$185.62/sh−1,525$283,071→ 54,673 total
Footnotes (2)
- [F1]The transaction was made pursuant to a previously adopted plan complying with Rule 10b5-1.
- [F2]These shares include 663 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. 2009 Amended and Restated Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited on the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount.